The following ones have lower mean VAF in targeted profiling studies than in Zhang et al. summary: PPP6C, GRIN2A, ARID2, APC, GNAQ, EGFR, FBXW7. Despite some shortcomings of the analyzed studies, we have selected 22 genes to be included in the melanoma genomic panel. This evidence concerns the gene ARID2 and melanoma.